Nalaganje...

A novel combinatorial cancer immunotherapy: poly-IC and blockade of the PD-1/PD-L1 pathway

A non-antigen specific immunotherapy consisting of repeated co-administration of poly-IC and blocking antibodies targeting the programmed cell death-1 (PD-1) pathway dramatically inhibits tumor development in several mouse models of cancer. Tumor-reactive CD8(+) T cells mediate the antitumor effects...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Nagato, Toshihiro, Celis, Esteban
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063146/
https://ncbi.nlm.nih.gov/pubmed/25050210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.28440
Oznake: Označite
Brez oznak, prvi označite!